PubRank

Silvia Sabbioni

Author PubWeight™ 58.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005 27.56
2 Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007 5.40
3 In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol 2012 2.27
4 MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2009 2.16
5 Open letter to Senator Rita Levi-Montalcini. Science 2008 2.02
6 MicroRNAs in human cancer: from research to therapy. J Cell Sci 2007 2.00
7 MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008 1.99
8 MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 2009 1.84
9 BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 2006 1.32
10 Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology 2012 1.23
11 Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer Res 2004 1.21
12 Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer. Mol Cancer 2007 1.17
13 Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 2004 1.10
14 Simian virus 40 in humans. Infect Agent Cancer 2007 1.09
15 microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem 2011 1.06
16 Role of microRNAs in hepatocellular carcinoma: a clinical perspective. Onco Targets Ther 2013 1.02
17 MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Radic Biol Med 2008 0.99
18 Anti-tumor activity of a miR-199-dependent oncolytic adenovirus. PLoS One 2013 0.93
19 miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs. Front Genet 2013 0.89
20 p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma. Mol Cancer Res 2013 0.84
21 MicroRNA response to environmental mutagens in liver. Mutat Res 2011 0.83
22 MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer. Eur J Cancer Prev 2012 0.76